BridgeBio Oncology Therapeutics Inc.
BBOT | NASDAQ
$4.66
$0 (0.00%)
Sep 22, 2026, 12:33 PM ET · Market open
TTM Period Ending | TTM 2026 Jun 29, 2026 | TTM 2026 Mar 30, 2026 | TTM 2025 Dec 30, 2025 | TTM 2025 Sep 29, 2025 | TTM 2025 Jun 29, 2025 | TTM 2025 Mar 30, 2025 | TTM 2024 Dec 30, 2024 | TTM 2024 Sep 29, 2024 | TTM 2024 Jun 29, 2024 | TTM 2024 Mar 30, 2024 | TTM 2023 Dec 30, 2023 | TTM 2023 Sep 29, 2023 | TTM 2022 Dec 30, 2022 | TTM 2021 Dec 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PE Ratio | -0.01 | -1.57 | -2.36 | -2.95 | -3.83 | -7.69 | -21.88 | -17.42 | 73.21 | 215 | -3.22 | n/a | -59.3K | -4.85K |
PEG Ratio | n/a | -0.20 | 0.07 | -0.05 | -0.13 | 0.01 | 0.19 | 0.02 | 0.83 | -0.08 | n/a | n/a | 593.02 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.58 | 0.30 | -0.22 | -0.22 | -0.05 | 0.56 | 1.20 | -819.96 | -820.29 | -1.09K | -3.28K | n/a | -9.54K | -11.37K |
P/FCF Ratio | 0 | -1.61 | -2.83 | -2.85 | -3.92 | -6.60 | -3.61 | -5.09 | -27.05 | -25.57 | -3.98 | n/a | n/a | n/a |
P/OCF Ratio | 0 | -1.62 | -2.85 | -2.87 | -3.93 | -6.61 | -3.61 | -5.09 | -27.09 | -25.61 | -4.01 | n/a | n/a | n/a |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.01 | 0 | 0 | 0 | -0.01 | 0 | n/a | -0.28 | -0.77 | -1.03 | -1.10 | -0.99 | -1.97 | -2.01 |
Quick Ratio | 9.08 | 9.21 | 9.14 | 8.71 | 9.40 | 14.65 | 35.79 | 33.19 | 29.16 | 30.14 | n/a | n/a | n/a | n/a |
Current Ratio | 9.08 | 9.21 | 9.14 | 8.71 | 9.40 | 14.65 | 35.79 | 33.19 | 29.16 | 30.14 | n/a | n/a | n/a | n/a |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -12.06% | -4.57% | 1.01% | 0.77% | 0.95% | -5.13% | -10.01% | 8.99% | 11.31% | 19.03% | 101.78K% | n/a | 16.09% | 236.19% |
Return on Assets | -10.74% | -11.69% | -12.85% | -13.22% | -13.16% | -11.34% | -9.72% | -10.31% | -8.06% | -6.92% | -19.44K% | n/a | -2.43% | -30.05% |
Return on Invested Capital | -13.06% | -14.49% | -16.01% | -16.20% | -16.02% | -13.12% | -10.58% | -167.48% | -164.92% | -215.70% | -992.51K% | n/a | -16.58% | -233.05% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove BBOT